Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 2018, SemperVirens Venture Capital is a prominent venture capital firm with approximately $300 million in assets under management (AUM). The firm has established a strong reputation for its focus on category-defining startups in the health tech, workforce/HR tech, and fintech sectors. With a portfolio of over 70 companies, SemperVirens has demonstrated a commitment to supporting innovative businesses that leverage artificial intelligence to solve complex industry challenges. The firm operates across multiple geographies, including China, Israel, and the United States, allowing it to tap into diverse markets and opportunities.
SemperVirens has successfully closed several funds, including the recent $177 million fund in March 2025, which indicates robust momentum in their investment activities. Their investment strategy encompasses various stages, from seed to Series C, with check sizes ranging from $500,000 to $5 million. This flexibility allows them to lead and follow in investments, catering to the specific needs of their portfolio companies.
What sets SemperVirens apart is its proprietary support system, SemperSystem, which connects portfolio companies with over 200 Fortune 500 advisors. This extensive network provides invaluable resources for go-to-market acceleration and customer acquisition, enhancing the growth potential of the startups they back. SemperVirens is dedicated to fostering innovation and driving productivity, collaboration, and financial resilience in the industries they target.
SemperVirens Venture Capital specializes in investing in category-defining startups that are at the forefront of innovation in health tech, workforce/HR tech, and fintech. The firm seeks to partner with companies that are not only leveraging artificial intelligence but are also addressing significant employer needs and transforming complex industries. Their investment focus is on businesses that are poised to enhance productivity, collaboration, and financial resilience through innovative solutions.
The firm is particularly interested in startups that are solving pressing challenges within their respective sectors. For instance, in health tech, they look for companies that are revolutionizing patient care and healthcare delivery through technology. In workforce/HR tech, they focus on solutions that improve employee engagement and streamline HR processes. In fintech, SemperVirens targets startups that are redefining financial services and enhancing accessibility for users.
With a check size range of $500,000 to $5 million, SemperVirens provides selective, stage-specific capital to support startups from seed through Series C. Their recent fund closes, including a $177 million fund, reflect their active deployment strategy and commitment to backing innovative companies that align with their investment thesis. By leveraging their extensive network of Fortune 500 advisors, SemperVirens aims to facilitate go-to-market strategies and accelerate the growth of their portfolio companies.
SemperVirens Venture Capital boasts a diverse portfolio of 124 investments, showcasing their commitment to supporting innovative startups across various sectors. Notable companies in their portfolio include Midi, Remote, SpringHealth, and Carrot Fertility, each of which exemplifies the firm's focus on category-defining leaders in health tech, workforce/HR tech, and fintech.
The firm has a strong track record of investment, with an average seed investment of $8.17 million, Series A average of $18.4 million, Series B average of $38.8 million, and Series C average of $86 million. This indicates their willingness to provide substantial capital to support the growth of their portfolio companies at different stages of development.
SemperVirens' recent $177 million fund close further underscores their active investment strategy and ability to deploy capital effectively. By leveraging their proprietary SemperSystem, which connects startups with over 200 Fortune 500 advisors, they enhance the potential for successful outcomes and exits within their portfolio.
To pitch SemperVirens, founders should prepare a detailed presentation that highlights their business model and market opportunity. Specific details about the pitch process are not provided, so it is recommended to reach out directly for further instructions.
SemperVirens Venture Capital operates one program, the SemperVirens Venture Capital initiative, which is designed to support startups in their growth journey. This program offers access to their extensive network of advisors and resources to facilitate go-to-market strategies and customer acquisition.
SemperVirens Venture Capital has been actively deploying capital, recently closing a $177 million fund in March 2025. This fund is indicative of their strong momentum in investment activities, with 9 investments made in the last 12 months. The firm continues to focus on supporting innovative startups that are transforming industries through AI and technology.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.